نتائج البحث - Trupti Paranjape
- يعرض 1 - 8 نتائج من 8
-
1
MicroRNAs: tools for cancer diagnostics حسب Trupti Paranjape, Frank J. Slack, Joanne B. Weidhaas
منشور في 2009Artigo -
2
-
3
microRNA miR-196a-2 and Breast Cancer: A Genetic and Epigenetic Association Study and Functional Analysis حسب Aaron E. Hoffman, Tongzhang Zheng, Chunhui Yi, Derek Leaderer, Joanne B. Weidhaas, Frank J. Slack, Yawei Zhang, Trupti Paranjape, Yongxue Zhu
منشور في 2009Artigo -
4
The mir-34 microRNA is required for the DNA damage response in vivo in C. elegans and in vitro in human breast cancer cells حسب Masaomi Kato, Trupti Paranjape, Robert L. Ullrich, Sunitha Nallur, Erin F. Gillespie, Katie Keane, Aurora Esquela‐Kerscher, Joanne B. Weidhaas, Frank J. Slack
منشور في 2009Artigo -
5
A <i>Let-7</i> MicroRNA SNP in the <i>KRAS</i> 3′UTR Is Prognostic in Early-Stage Colorectal Cancer حسب Kim M. Smits, Trupti Paranjape, Sunitha Nallur, Kristien Wouters, Matty P. Weijenberg, Leo J. Schouten, Piet A. van den Brandt, Fred T. Bosman, Joanne B. Weidhaas, Manon van Engeland
منشور في 2011Artigo -
6
A 3′-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis حسب Trupti Paranjape, Helen Heneghan, Robert Lindner, Florence K. Keane, Aaron E. Hoffman, Antoinette Hollestelle, Jemima Dorairaj, Kimberly Geyda, Cory Pelletier, Sunitha Nallur, John W.M. Martens, Maartje J. Hooning, Michael J. Kerin, Daniel Zelterman, Yongxue Zhu, David Tuck, Lyndsay N. Harris, Nicola Miller, Frank J. Slack, Joanne B. Weidhaas
منشور في 2011Artigo -
7
A <i>KRAS</i>-Variant in Ovarian Cancer Acts as a Genetic Marker of Cancer Risk حسب Elena Ratner, Lingeng Lu, Marta Boeke, Rachel Barnett, Sunitha Nallur, Lena J. Chin, Cory Pelletier, Rachel Blitzblau, Renata Tassi, Trupti Paranjape, Pei Hui, Andrew K. Godwin, Herbert Yu, Harvey A. Risch, Thomas Rutherford, Peter E. Schwartz, Alessandro D. Santin, Ellen Matloff, Daniel Zelterman, Frank J. Slack, Joanne B. Weidhaas
منشور في 2010Artigo -
8
A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer حسب Elena Ratner, Florence K. Keane, Robert Lindner, Renata Tassi, Trupti Paranjape, Michelle Glasgow, Sunitha Nallur, Yanxiang Deng, Lingeng Lu, Linda Steele, Sharon Sand, R-U Muller, Eliana Bignotti, Stefania Bellone, Marta Boeke, Xinyi Yao, S. Pecorelli, Antonella Ravaggi, Dionyssios Katsaros, Daniel Zelterman, Mihaela Cristea, Hon J. Yu, Thomas Rutherford, Jeffrey N. Weitzel, Susan L. Neuhausen, Peter E. Schwartz, Frank J. Slack, Alessandro D. Santin, Joanne B. Weidhaas
منشور في 2011Artigo
أدوات البحث:
موضوعات ذات صلة
Biology
Gene
Genetics
Cancer
Medicine
Internal medicine
microRNA
Cancer research
KRAS
Oncology
Colorectal cancer
Breast cancer
Cell cycle
Oncogene
Allele
Bioinformatics
Confidence interval
Hazard ratio
Ovarian cancer
Biomarker
Caenorhabditis elegans
Cancer cell
Carcinogenesis
Cell biology
Cell culture
Chemotherapy
Cohort
Computational biology
DNA
DNA damage